Megamika 250mg Injection
Marketer
Mapra Laboratories Pvt Ltd
Salt Composition
Amikacin (250mg)
Overview Megamika 250mg Injection
Cefamika 250mg Injection, a broad-spectrum antibiotic, combats numerous bacterial infections. These infections can affect various body systems, including the urinary tract, skeletal system, respiratory system (like pneumonia), central nervous system, and circulatory system. Prophylactic use is common in hospitalized individuals to avert infections. Cefamika 250mg Injection inhibits bacterial proliferation. Administered intravenously or intramuscularly by a healthcare provider, self-injection is strictly prohibited. Adherence to the prescribed dosage schedule is crucial; incomplete treatment may result in relapse or infection exacerbation. Typical side effects include injection site inflammation and elevated blood urea nitrogen. Persistent side effects or treatment ineffectiveness necessitate medical consultation. High doses may exceptionally cause vertigo, nephrotoxicity, and ototoxicity. Therefore, rigorous adherence to medical guidance is essential, potentially including regular kidney, hearing, and urine assessments. Pregnancy is a contraindication; disclose pregnancy, pregnancy intentions, or breastfeeding to your physician.
Uses of Megamika 250mg Injection
Infections caused by bacteria
Major Benefits of Megamika 250mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Megamika 250mg Injection:
- Increased blood urea
- Injection site reactions (pain, swelling, redness)
How to use Megamika 250mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How Megamika 250mg Injection works:
Mikamycin 250mg Injection is a bacterial growth inhibitor. Its mechanism of action involves disrupting the production of crucial bacterial proteins, thus hindering their essential life processes.
SAFETY ADVICE
AlcoholSAFE
Megamika 250mg Injection may be used concurrently with alcohol without adverse reactions.
PregnancyCONSULT YOUR DOCTOR
Administering Megamika 250mg Injection during pregnancy poses a confirmed risk to fetal development, making it contraindicated. Exceptions might exist in critical circumstances where a physician deems the potential benefits outweigh the inherent dangers. Physician consultation is essential.
Breast feedingSAFE IF PRESCRIBED
The 250mg Megamika injection poses minimal risk during lactation. Research in humans indicates negligible transfer into breast milk, presenting no apparent danger to the infant.
DrivingUNSAFE
Administering Megamika 250mg Injection can induce drowsiness, blurred vision, and dizziness, potentially impairing alertness. Driving should be avoided if these effects manifest.
KidneyCAUTION
Individuals with impaired kidney function should exercise caution when using Megamika 250mg Injection. A modified dosage of Megamika 250mg Injection may be necessary. Medical advice is recommended.
LiverSAFE IF PRESCRIBED
Administering a 250mg Megamika Injection to patients with hepatic impairment is likely safe. Available evidence indicates dose modification may be unnecessary; however, physician consultation is recommended.
What if you forget to take Megamika 250mg Injection :
Omit a Megamika 250mg Injection? Seek medical advice immediately.
Facts to Know About Megamika 250mg Injection
| Label | Value |
|---|---|
| Chemical Category | Aminoglycoside antibiotics |
| Developing Habits | No. |
| Treatment Category | Antimicrobial Agents |
| Action Class | Aminoglycoside antibiotics |
3,018 People bought this recently